These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells. Yamasaki T; Suzuki A; Hasebe R; Horiuchi M PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483 [TBL] [Abstract][Full Text] [Related]
11. Cells and prions: a license to replicate. Nuvolone M; Aguzzi A; Heikenwalder M FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in the histo-molecular pathology of human prion disease. Baiardi S; Rossi M; Capellari S; Parchi P Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of neurotoxicity of pathological prion protein. Castilla J; Hetz C; Soto C Curr Mol Med; 2004 Jun; 4(4):397-403. PubMed ID: 15354870 [TBL] [Abstract][Full Text] [Related]
15. The Prion Concept and Synthetic Prions. Legname G; Moda F Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659 [TBL] [Abstract][Full Text] [Related]
16. Proteomics applications in prion biology and structure. Moore RA; Faris R; Priola SA Expert Rev Proteomics; 2015 Apr; 12(2):171-84. PubMed ID: 25795148 [TBL] [Abstract][Full Text] [Related]
17. The pathogenic mechanisms of prion diseases. Unterberger U; Voigtländer T CNS Neurol Disord Drug Targets; 2007 Dec; 6(6):424-55. PubMed ID: 18220781 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol and its reciprocal association with prion infection. Cashion J; Zhang W; Ali T; Gilch S Cell Tissue Res; 2023 Apr; 392(1):235-246. PubMed ID: 35821439 [TBL] [Abstract][Full Text] [Related]
19. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations. Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein. Homma T; Ishibashi D; Nakagaki T; Satoh K; Sano K; Atarashi R; Nishida N Sci Rep; 2014 Mar; 4():4504. PubMed ID: 24675871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]